Oscar Health, Inc. (OSCR) stock
OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3026% above fair value
$27.57−2.27 (-7.61%)
Close on Nov 18, 2026Market cap $8.51BP/E 19.7Yield –
Oscar Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Oscar Health's operating income for the twelve months ending Jun 30, 2026 was $629.72M. For fiscal 2025 it was -$396.36M, down 792.1% from the year before. The highest annual figure on record is $57.27M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$396.36M | -792.1% |
| FY2024 | Dec 31, 2024 | $57.27M | – |
| FY2023 | Dec 31, 2023 | -$235.62M | – |
| FY2022 | Dec 31, 2022 | -$589.87M | – |
| FY2021 | Dec 31, 2021 | -$544.48M | – |
| FY2020 | Dec 31, 2020 | -$402.27M | – |
| FY2019 | Dec 31, 2019 | -$259.39M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $388.64M | – |
| Q1 FY2026 | Mar 31, 2026 | $704.09M | +137.0% |
| Q4 FY2025 | Dec 31, 2025 | -$333.75M | – |
| Q3 FY2025 | Sep 30, 2025 | -$129.25M | – |
| Q2 FY2025 | Jun 30, 2025 | -$230.48M | -439.9% |
| Q1 FY2025 | Mar 31, 2025 | $297.12M | +60.1% |
| Q4 FY2024 | Dec 31, 2024 | -$147.73M | – |
| Q3 FY2024 | Sep 30, 2024 | -$48.37M | – |
| Q2 FY2024 | Jun 30, 2024 | $67.81M | – |
| Q1 FY2024 | Mar 31, 2024 | $185.56M | – |
| Q4 FY2023 | Dec 31, 2023 | -$145.48M | – |
| Q3 FY2023 | Sep 30, 2023 | -$58.24M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.53M | – |
| Q1 FY2023 | Mar 31, 2023 | -$25.37M | – |
| Q4 FY2022 | Dec 31, 2022 | -$222.48M | – |
| Q3 FY2022 | Sep 30, 2022 | -$192.37M | – |
| Q2 FY2022 | Jun 30, 2022 | -$106.49M | – |
| Q1 FY2022 | Mar 31, 2022 | -$68.53M | – |
| Q4 FY2021 | Dec 31, 2021 | -$196.25M | – |
| Q3 FY2021 | Sep 30, 2021 | -$211.68M | – |
| Q2 FY2021 | Jun 30, 2021 | -$72.51M | – |
| Q1 FY2021 | Mar 31, 2021 | -$64.04M | – |
| Q4 FY2020 | Dec 31, 2020 | -$186.84M | – |
| Q3 FY2020 | Sep 30, 2020 | -$80.13M | – |
| Q2 FY2020 | Jun 30, 2020 | -$39.35M | – |
| Q1 FY2020 | Mar 31, 2020 | -$95.95M | – |
See a number that looks wrong?